MTOR and pneumonitis: Drug-induced pneumonitis is a recognized yet often underdiagnosed complication of mammalian target of rapamycin (mTOR) inhibitors - immunosuppressive agents such as everolimus that block cellular proliferation pathways - particularly among solid organ transplant recipients.